Consolidated Statements of Shareholders' Equity (Deficiency) - USD ($)
|
Total |
Common Stock |
Additional Paid-In Capital |
Accumulated Other Comprehensive Income |
Accumulated Deficit |
| Balance, shares at Nov. 30, 2018 |
|
18,252,243
|
|
|
|
| Balance, amount at Nov. 30, 2018 |
$ 4,102,307
|
$ 44,327,952
|
$ 45,110,873
|
$ 284,421
|
$ (85,620,939)
|
| Stock options to employees (Note 11) |
264,568
|
$ 0
|
264,568
|
0
|
0
|
| Shares issued upon exercise of 2018 Pre-Funded Warrants (Note 14), shares |
|
3,823,334
|
|
|
|
| Shares issued upon exercise of 2018 Pre-Funded Warrants (Note 14), amount |
27,953
|
$ 1,007,658
|
(979,705)
|
0
|
0
|
| Shares issued upon exercise of DSUs (Note 12), shares |
|
10,279
|
|
|
|
| Shares issued upon exercise of DSUs (Note 12), amount |
0
|
$ 225,612
|
(225,612)
|
0
|
0
|
| Beneficial conversion feature related to Debentures (Note 7) |
8,639
|
0
|
8,639
|
0
|
0
|
| Deferred tax expense related to beneficial conversion feature (Note 15) |
(11,042)
|
0
|
(11,042)
|
0
|
0
|
| Net loss |
(8,084,646)
|
$ 0
|
0
|
0
|
(8,084,646)
|
| Balance, shares at Nov. 30, 2019 |
|
22,085,856
|
|
|
|
| Balance, amount at Nov. 30, 2019 |
(3,692,221)
|
$ 45,561,222
|
44,167,721
|
284,421
|
(93,705,585)
|
| Stock options to employees (Note 11) |
71,645
|
$ 0
|
71,645
|
0
|
0
|
| Shares issued upon exercise of 2018 Pre-Funded Warrants (Note 14), shares |
|
1,592,249
|
|
|
|
| Shares issued upon exercise of 2018 Pre-Funded Warrants (Note 14), amount |
0
|
$ 583,180
|
(583,180)
|
0
|
0
|
| Beneficial conversion feature related to Debentures (Note 7) |
697,952
|
0
|
697,952
|
0
|
0
|
| Net loss |
(3,390,965)
|
$ 0
|
0
|
0
|
(3,390,965)
|
| Balance, shares at Nov. 30, 2020 |
|
23,678,105
|
|
|
|
| Balance, amount at Nov. 30, 2020 |
(6,313,589)
|
$ 46,144,402
|
44,354,138
|
284,421
|
(97,096,550)
|
| Stock options to employees (Note 11) |
11,985
|
0
|
11,985
|
0
|
0
|
| Beneficial conversion feature related to Debentures (Note 7) |
354,167
|
0
|
354,167
|
0
|
0
|
| Deferred tax expense related to beneficial conversion feature (Note 15) |
(93,854)
|
0
|
(93,854)
|
0
|
0
|
| Net loss |
(5,145,155)
|
$ 0
|
0
|
0
|
(5,145,155)
|
| Proceeds from private placemtn financing (Note 10), shares |
|
9,414,560
|
|
|
|
| Proceeds from private placemtn financing (Note 10), amount |
3,069,448
|
$ 3,069,448
|
0
|
0
|
0
|
| Cost of private placement financing (Note 10) |
(38,220)
|
$ (38,220)
|
0
|
0
|
0
|
| Balance, shares at Nov. 30, 2021 |
|
33,092,665
|
|
|
|
| Balance, amount at Nov. 30, 2021 |
$ (8,155,218)
|
$ 49,175,630
|
$ 44,626,436
|
$ 284,421
|
$ (102,241,705)
|